Further analyses indicated that the APOE-ε4ε4 haplotype carriers were less likely to participate in the MHQ and high genetic liability for Alzheimer’s disease lowered odds of participation in the FFQ, physical activity monitoring and the MHQ. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.